Cureskin Raises $20 Million in Series B Funding to Expand Access to AI-Driven Dermatological Care in India
HealthQuad leads funding round to support Cureskin‘s mission of providing quality skin and hair health solutions
Funding News: Cureskin, an AI-driven dermatology platform offering clinically validated skin and hair health solutions, has successfully raised $20 million in Series B funding. The round was led by HealthQuad, a prominent digital health-focused venture capital fund in India. Existing investors, including JSW Ventures, Khosla Ventures, and Sharrp Ventures, also participated. This latest investment brings Cureskin’s total funding to $26 million, enabling the company to further its vision of expanding access to high-quality dermatological care throughout India.
Addressing the significant shortage of qualified dermatologists in the country, Cureskin aims to bridge the gap by leveraging AI technology to scale the reach of dermatologists. Through its mobile app, Cureskin has already treated over 1.5 million customers, predominantly in Tier 2 and 3 regions, for various skin conditions such as acne, hyper-pigmentation, post-acne issues, and hair loss.
Guna Kakulapati, CEO and Co-founder of Cureskin, expressed his delight at securing the support of HealthQuad and existing partners. He emphasized the growing demand for accessible expertise and quality care to address skin and hair problems in India. The funds raised will be utilized to enhance Cureskin’s AI capabilities, accelerate growth, and expand solution offerings, ultimately aiming to provide optimal skin and hair health to millions of individuals across the country.
Related post – Tin Men Capital Backs Ai Palette: Spearheading Beauty & Personal Care Innovation with Generative AI Breakthroughs!
Cureskin differentiates itself from other beauty and personal care brands in the market by offering dermatologist-prescribed, continuously-monitored, high-efficacy personalized solutions at affordable prices. This approach ensures that consumers receive tailored treatment plans based on their specific needs, solving the challenge of product choices in an overcrowded market.
Dr. Pinak Shrikhande, Managing Director of HealthQuad, highlighted the lack of qualified dermatologists in Tier 3+ towns and the resulting ineffective self-treatments due to a lack of product knowledge. He praised Cureskin’s comprehensive digital-first platform, which utilizes AI-led diagnosis to provide customized skin and hair care treatments. By offering high-quality outcome-driven regimens at affordable prices, Cureskin addresses the accessibility, affordability, and quality issues in dermatological care.
Sachin Tagra, Managing Partner at JSW Ventures, commended Cureskin’s exemplary execution capabilities and expressed confidence that the funding would enable the company to scale its operations, innovate in AI development, and expand distribution capabilities.
Cureskin’s success in delivering measurable outcomes is evident, with a 98% treatment success rate for skin conditions within three months of adherence. The company’s holistic approach includes understanding the root causes of individual needs, providing diet and lifestyle guidance, and facilitating regular follow-ups with dermatologists.
Veda Corporate Advisors served as the exclusive advisors to Cureskin for this transaction.
About Cureskin:
Cureskin is an AI-enabled app that offers personalized skin and hair care solutions across India, with dermatologist-prescribed treatments. The company takes a holistic approach to address individual needs, focusing on root-cause understanding, diet/lifestyle guidance, and regular dermatologist follow-ups to ensure improved outcomes. With a 98% treatment success rate for skin conditions within three months, Cureskin is committed to providing accessible and effective dermatological care.
About HealthQuad:
HealthQuad is a leading digital health-focused venture capital fund in India, managing assets of over $280 million across two funds. The fund’s focus is on nurturing innovative models that significantly improve healthcare access and affordability through technology-driven solutions.
